Patients who start renal replacement therapy (RRT) for End-Stage Kidney Disease (ESKD) without having had timely access to specialist renal services have poor outcomes. At one NHS Trust in England, a community-wide CKD management system has led to a decline in the incident rate of RRT and the lowest percentage of patients presenting within 90 days of starting RRT in the UK. We describe the protocol for a quality improvement project to scale up and evaluate this innovation.
The intervention is based upon an off-line database that integrates laboratory results from blood samples taken in all settings stored under different identifying labels relating to the same patient. Graphs of estimated glomerular filtration rate (eGFR) over time are generated for patients <65 years with an incoming eGFR <50 ml/min/1.73 m2 and patients >65 years with an incoming eGFR <40 ml/min/1.73 m2. Graphs where kidney function is deteriorating are flagged by a laboratory scientist and details sent to the primary care doctor (GP) with a prompt that further action may be needed.
We will evaluate the impact of implementing this intervention across a large population served by a number of UK renal centres using a mixed methods approach. We are following a stepped-wedge design. The order of implementation among participating centres will be randomly allocated. Implementation will proceed with unidirectional steps from control group to intervention group until all centres are generating graphs of eGFR over time.
The primary outcome for the quantitative evaluation is the proportion of patients referred to specialist renal services within 90 days of commencing RRT, using data collected routinely by the UK Renal Registry. The qualitative evaluation will investigate facilitators and barriers to adoption and spread of the intervention. It will include: semi-structured interviews with laboratory staff, renal centre staff and service commissioners; an online survey of GPs receiving the intervention; and focus groups of primary care staff.
Late presentation to nephrology for patients with ESKD is a source of potentially avoidable harm. This protocol describes a robust quantitative and qualitative evaluation of a quality improvement intervention to reduce late presentation and improve the outcomes for patients with ESKD.
Health and Social Care Information Centre. Health survey for England, volume 1: Health and Lifestyles. 2009.
Chronic Kidney Disease Prognosis Consortium, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375(9731):2073–81. CrossRef
Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis Off J Natl Kidney Found. 1998;32(5 Suppl 3):S112–9. CrossRef
Gilg J, Caskey FJ, Fogarty D. UK renal registry 18th annual report: chapter 1 UK renal replacement therapy incidence in 2014: National and Centre-specific Analyses. Nephron 2016;132(suppl1):9–40.
Rayner HC, Baharani J, Dasgupta I, Suresh V, Temple RM, Thomas ME, et al. Does community-wide chronic kidney disease management improve patient outcomes? Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 2014;29(3):644–9.
Hemming K, Girling A. A menu-driven facility for power and detectable-difference calculations in stepped-wedge cluster-randomized trials. Stata J. 2014;14(2):363–80.
National Institute for Health Research. Patient and public involvement in health and social care research: a handbook for researchers [Internet]. 2014. Available from: http://www.rdslondon.co.uk/rdslondon/media/rdscontent/files/pdfs/rds_ppi-handbook_web.pdf.
National Institute for Health and Care Excellence. Chronic kidney disease: early identification and management of chronic kidney disease in adults in primary and secondary care [Internet]. 2014. Available from: https://www.nice.org.uk/guidance/cg182.
Jones RK, Hampton D, O’Sullivan DJ, Phillips AO. Diabetes and renal disease: who does what? Clin Med Lond Engl. 2013;13(5):460–4. CrossRef
UK Renal Registry. The ninth annual report. 2006.
Perspectives on context [Internet]. Health Foundation. [cited 2015 Mar 4]. Available from: http://www.health.org.uk/publications/perspectives-on-context.
Project Initiation Document Implementation of a kidney function surveillance and reporting system for progressive Chronic Kidney Disease across the West Midlands [Internet]. Available from: www.wmscnsenate.nhs.uk/index.php/download_file/view/207/978/Cached. Accessed July 2014.
Baily MA, Bottrell M, Lynn J, Jennings B. The ethics of using QI methods to improve health care quality and safety. New York: Hastings Center; 2006.
Dixon, N. Guide to managing ethical issues in quality improvement or clinical audit projects [Internet]. Healthcare Quality Improvement Partnership; 2017. Available from: http://www.hqip.org.uk/resources/ethicsfor-clinical-audit-and-qi/.
Udayaraj UP, Haynes R, Winearls CG. Late presentation of patients with end-stage renal disease for renal replacement therapy--is it always avoidable? Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 2011;26(11):3646–51.
- A programme to spread eGFR graph surveillance for the early identification, support and treatment of people with progressive chronic kidney disease (ASSIST-CKD): protocol for the stepped wedge implementation and evaluation of an intervention to reduce late presentation for renal replacement therapy
Charles R. V. Tomson
Fergus J. Caskey
Stephen J. Walters
Hugh C. Rayner
- BioMed Central
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II